---
title: "Prognostic value of home blood pressure monitoring in patients…"
description: "Home blood pressure monitoring independently predicts cardiovascular events in people already being treated for high blood pressure."
url: "https://magellanlongevity.com/study/d36163509.md"
canonical: "https://magellanlongevity.com/study/d36163509.html"
html: "https://magellanlongevity.com/study/d36163509.html"
type: "study"
study_key: "d36163509"
journal: "J Hum Hypertens"
year: 2022
pmid: "36163509"
doi: "10.1038/s41371-022-00758-x"
citations: 1
updated: 2026-09-02
author: "Gabriel Radu, DO"
author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765."
publisher: "Magellan Longevity"
content_format: "markdown"
---

# Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment

[Home](https://magellanlongevity.com/) › [Research map](https://magellanlongevity.com/longevity-research-map.html) › Prognostic value of home blood pressure monitoring in…

**HTML version:** https://magellanlongevity.com/study/d36163509.html · **In the Magellan app:** https://magellanlongevity.com/#/study/d36163509

## Citation

| Field | Value |
| --- | --- |
| Journal | J Hum Hypertens |
| Year | 2022 |
| PMID | [36163509](https://pubmed.ncbi.nlm.nih.gov/36163509/) |
| DOI | [10.1038/s41371-022-00758-x](https://doi.org/10.1038/s41371-022-00758-x) |
| Study key | d36163509 |

## Takeaway

Home blood pressure monitoring independently predicts cardiovascular events in people already being treated for high blood pressure.

## The question

Does home blood pressure monitoring (HBPM) have prognostic value for cardiovascular events in treated hypertensive patients?

## Hypothesis

The prognostic value of HBPM in treated hypertensive subjects is controversial, and this study aims to evaluate it.

## Methods

Medicated hypertensive patients who performed a 4-day HBPM between 2008 and 2015 were followed for a median of 5.9 years. The occurrence of a composite primary outcome of fatal and non-fatal cardiovascular events was registered. Cox regression models were used to analyze the prognostic value of HBPM, considering 4-day measurements (discarding the first day) and analyzing morning, afternoon, and evening periods separately. The analysis included 1582 patients.

## Results

During follow-up, 273 cardiovascular events occurred. HBPM was significantly associated with cardiovascular events in all five scenarios in unadjusted models. After adjusting for office BP and other cardiovascular risk factors, the association remained marginally significant for the 4-day period (HR 1.04 [95% CI 1-1.1] and 1.04 [95% CI 1-1.1] when discarding the first day). The association was statistically significant for all separate measurement periods: morning (HR 1.32 [95% CI 1.01-1.72]), afternoon (HR 1.33 [95% CI 1.02-1.72]), and evening (HR 1.30 [95% CI 1.01-1.67]). When fatal and non-fatal events were analyzed separately, statistical significance was only maintained for fatal events.

## Conclusion

HBPM is an independent predictor of cardiovascular events in hypertensive patients undergoing treatment.

## Limitations

The abstract does not explicitly state limitations of the study.

## Verbatim from the abstract

> home blood pressure monitoring is an independent predictor of cardiovascular events

## Hazard Ratios for Cardiovascular Events by HBPM Measurement Period

| Measure | Hazard Ratio |
| --- | --- |
| Morning | 1.32 |
| Afternoon | 1.33 |
| Evening | 1.3 |

*Hazard ratios for cardiovascular events, adjusted for office BP and other cardiovascular risk factors, across different home blood pressure monitoring periods.*

## Where this study is used on Magellan

This paper is one of the citations behind the evidence grade on the pages below. Grades are assigned from the published research and are independent of affiliate commissions.

| Compound or device | Evidence grade | Graded pages |
| --- | --- | --- |
| Validated Home BP Monitor | Strong evidence | [Validated Home BP Monitor](https://magellanlongevity.com/p/163.md) |

## Reference

1. **Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment**
   J Hum Hypertens 2022 · [PMID 36163509](https://pubmed.ncbi.nlm.nih.gov/36163509/) · [DOI 10.1038/s41371-022-00758-x](https://doi.org/10.1038/s41371-022-00758-x)

   > home blood pressure monitoring is an independent predictor of cardiovascular events

## Structured data

```json
{"@context":"https://schema.org","@graph":[{"@type":"MedicalWebPage","@id":"https://magellanlongevity.com/study/d36163509.html#page","url":"https://magellanlongevity.com/study/d36163509.html","name":"Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment","description":"Home blood pressure monitoring independently predicts cardiovascular events in people already being treated for high blood pressure.","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/study/d36163509.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Research map","item":"https://magellanlongevity.com/longevity-research-map.html"},{"@type":"ListItem","position":3,"name":"Prognostic value of home blood pressure monitoring in…","item":"https://magellanlongevity.com/study/d36163509.html"}]},{"@type":"ScholarlyArticle","@id":"https://magellanlongevity.com/study/d36163509.html#study","name":"Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment","headline":"Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment","datePublished":"2022","isPartOf":{"@type":"Periodical","name":"J Hum Hypertens"},"identifier":"PMID:36163509","url":"https://pubmed.ncbi.nlm.nih.gov/36163509/","sameAs":"https://doi.org/10.1038/s41371-022-00758-x","abstract":"Home blood pressure monitoring independently predicts cardiovascular events in people already being treated for high blood pressure."}]}
```

## Related on Magellan Longevity

- [Validated Home BP Monitor](https://magellanlongevity.com/p/163.md) — product graded on this and related evidence
- [Evidence: oscillometric arterial pressure](https://magellanlongevity.com/study/s163.md)
- [Evidence: Blood pressure level and variability](https://magellanlongevity.com/study/s155.md)
- [Longevity research map](https://magellanlongevity.com/longevity-research-map.html)
- [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md)

## Scope and disclosures

Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication.

Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases.

Reviewed for accuracy by a board-certified physician (DO).